Canonsburg

Viatris Sees Vision Drugs as Key to Growth and Commits $750M to Two M&A Deals

Two years after the close of the merger that formed Viatris, the company is acquiring Oyster Point Pharma and Famy Life Sciences to expand its scope in ophthalmology, one of three therapeutic areas it is now focusing on for revenue growth.

By Frank Vinluan

BioPharma, Pharma

Biocon expands portfolio & market reach with $3.3B buyout of Viatris biosimilars

Biocon Biologics is acquiring the biosimilars business of its longtime partner, Viatris. The deal gives Biocon a biosimilars presence in both emerging and developed markets, while Viatris sheds non-core assets as part of a broader strategic review.

By Frank Vinluan

Health IT

Reducing Clinical and Staff Burnout with AI Automation

As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.

By Dr. Michael Blackman, Chief Medical Officer at Greenway Health

Consumer / Employer

Health Executives on Digital Transformation in Healthcare

Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

By MedCity News

Health IT

Transforming Patient Care: The Role of AI-Powered Assistants

The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.

By IT Medical

Health IT

Transforming Patient Care: The Role of AI-Powered Assistants

The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.

By IT Medical